Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return.
Chemistry
; 22(24): 8048-52, 2016 Jun 06.
Article
em En
| MEDLINE
| ID: mdl-27139720
The free-energy surface (FES) of protein-ligand binding contains information useful for drug design. Here we show how to exploit a free-energy minimum of a protein-ligand complex identified by metadynamics simulations to design a new EphA2 antagonist with improved inhibitory potency.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Desenho de Fármacos
/
Receptor EphA2
Limite:
Humans
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article